Adeno-associated virus (AAV) is one of the most actively investigated gene therapy vehicles. Now, under the leadership of Prof Chris Shaw, Associate Director of UK DRI at Kings, the institute will be at the forefront of realising this potential.
Read more
On Saturday 15 June, UK DRI joined MRC units from across UCL to transform South Cloisters into a Summer Science Fete, as part of the MRC Festival. A family fun day, over 300 attendees met scientists and learnt about current research, from experimenting with ‘Quack Quack’ disease to taking a ‘cell-fie’.
Read more
The UK DRI has joined major European institutions in launching a petition that urges the EU to give greater emphasis to neuroscience research in its upcoming strategic and funding plan for Horizon Europe.
Read more
The UK DRI is made up of people who choose to take the road less travelled, and we run schemes to encourage and reward this. This spring, we launched our ‘Pilot Studies Programme’ and today five successful UK DRI applications have been selected.
Read more
A new paper published in the journal Alzheimer’s & Dementia: Translational Research & Clinical Interventions outlines six key issues in dementia research, along with practical recommendations for how the field should tackle them in order to increase success in therapeutic translation.
Read moreThe UK DRI focuses on innovative, early-stage science to advance our understanding of how dementias develop and progress. With hundreds of positions available, across all levels, see how you can be part of it and build your career at the UK DRI.
Join us
On 27 June, an international forum of scientists came together at King’s College London to examine the core biology of the synapse and explore possible reasons for its demise in pathological conditions. We take a look at what was discussed, and some key messages taken from the day.
Read more
The £1.63M gift from Lily Safra and the Edmond J. Safra Foundation will support fellowships for rising stars in Parkinson's Disease research.
Read moreWe are joining The Crick, and 29 Nobel prize winning scientists, in this call.
Our aim is to bring a solution for all dementias. This is by definition an international and long-term aim: we cannot tackle this problem in isolation.
The UK is a leader in the European science landscape but the current uncertainty around Brexit is already endangering this position. The prospect of a hard Brexit would dramatically affect the ability of the UK to attract and retain the brightest minds, seriously undermining the UK’s world leading role in scientific research and innovation, and ultimately impacting our ability to improve lives.
